- Home
- SYBT vs TWST Comparison
SYBT vs TWST Comparison
Compare SYBT & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBT
- TWST
- Stock Information
- Founded
- SYBT 1904
- TWST 2013
- Country
- SYBT United States
- TWST United States
- Employees
- SYBT N/A
- TWST N/A
- Industry
- SYBT Major Banks
- TWST Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SYBT Finance
- TWST Health Care
- Exchange
- SYBT Nasdaq
- TWST Nasdaq
- Market Cap
- SYBT 2.2B
- TWST 1.8B
- IPO Year
- SYBT N/A
- TWST 2018
- Fundamental
- Price
- SYBT $78.85
- TWST $36.40
- Analyst Decision
- SYBT Hold
- TWST Buy
- Analyst Count
- SYBT 3
- TWST 10
- Target Price
- SYBT $80.33
- TWST $49.10
- AVG Volume (30 Days)
- SYBT 109.6K
- TWST 1.1M
- Earning Date
- SYBT 07-23-2025
- TWST 08-01-2025
- Dividend Yield
- SYBT 1.57%
- TWST N/A
- EPS Growth
- SYBT 16.29
- TWST N/A
- EPS
- SYBT 4.14
- TWST N/A
- Revenue
- SYBT $353,277,000.00
- TWST $347,680,000.00
- Revenue This Year
- SYBT $14.39
- TWST $22.58
- Revenue Next Year
- SYBT $5.04
- TWST $17.71
- P/E Ratio
- SYBT $19.06
- TWST N/A
- Revenue Growth
- SYBT 8.97
- TWST 25.30
- 52 Week Low
- SYBT $47.60
- TWST $27.12
- 52 Week High
- SYBT $79.85
- TWST $60.90
- Technical
- Relative Strength Index (RSI)
- SYBT 64.68
- TWST 61.25
- Support Level
- SYBT $72.76
- TWST $34.85
- Resistance Level
- SYBT $78.94
- TWST $37.72
- Average True Range (ATR)
- SYBT 1.93
- TWST 1.79
- MACD
- SYBT 0.29
- TWST 0.49
- Stochastic Oscillator
- SYBT 98.24
- TWST 85.91
About SYBT Stock Yards Bancorp Inc.
Stock Yards Bancorp Inc operates as a bank. The bank has two reportable operating segments namely Commercial Banking and Wealth Management and Trust. Its services include loan and deposit services, cash management services, securities brokerage activities, mortgage origination, and others. It generates the majority of its revenue from the Commercial Banking segment.
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.